Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
| Brand name | LISINOPRIL |
| Generic name | LISINOPRIL |
| Active ingredient(s) | LISINOPRIL |
| Distributed by / for | Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 |
| NDC | 68180-980-03 |
| Full product label | Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Product was distributed to major distributors/wholesalers nationwide. |
| Quantity | 11,802 1000-count bottles |
| Recall initiated | 2022-09-13 |
| Report date | 2022-09-21 |
| Recall completed | 2024-01-31 |
| Recall number | D-1536-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗